TL;DR pump.science & BIO are teaming up to power streamlined drug testing for BioDaos on Solana, starting with VitaDAO. Molecule is announcing the DeSci Ecosystem Grant w/ half its BIO token allocation Molecule has acquired $100k in $RIF and $100k i

In a recent episode of The DeSci Podcast, we welcomed Krister Kauppi, founder Rapamycin Longevity Lab, and Dr Mitchell Lee, CEO and co-founder at Ora Biomedical.

In light of the rapid technological advancements of our time, particularly in artificial intelligence and distributed ledger technology (DLT), the need to address the pain points of traditional science is becoming increasingly urgent.

Last year the AthenaDAO community chose to support Dr Mario Cordero’s work on ovarian aging. We’re excited to share the team’s promising data and announce a further fundraising round to move the project forward.

Let's face it, death is the final boss. It's the game over screen nobody wants to see. But what if you could develop your own infinite health cheat code? What if we could keep playing the game indefinitely? Let's play on pump.science.

Molecule is building a Solana-native DeSci funding platform: pump.science. Read on for more!

Molecule's platform, Catalyst, empowers individuals to directly back scientific research projects that resonate with them. We are thrilled to announce our integration with Privy, a step that amplifies accessibility and usability for our community.

An important research milestone was reached — data showed ArtanBio’s AAV9-based gene therapy for aging has activity in vitro. This milestone demonstrates the power democratized funding can have towards advancing scientific progress. Read on for more.

Welcome to Catalyst, the DeSci funding machine that lets you decide the future of science.

With the beta launch of Catalyst, Molecule invites you to embark on an exciting journey with Catalyst Quests—a gamified adventure designed to onboard users into the DeSci movement.

Early-stage biomedical research funding is plagued by a mismatch between funded and impactful research. This disconnect results in significant diseases being underfunded despite their impact on public health.

Molecule, a leader in decentralized science (DeSci) and a pioneer in tokenized intellectual property (IP), is thrilled to announce its strategic partnership with CryoDAO.

We don’t know about you, but we’re still processing all the incredible ideas and information shared at this year's DeSci.Berlin!

Ringing in 2024, longevity stalwart VitaDAO has funded Dr. Michael Torres’ work to nullify a nonsense mutation that is implicated in a wide range of cancers and age-related diseases.

Sharing a mission of supporting early stage life sciences research and development, Molecule and Nucleate are joining forces to cultivate the next generation of bioentrepreneurs.

Dr Jack Scannell has been at the forefront of diagnosing the problems in biopharma research and development (R&D). As one of Molecule’s advisors, his work has inspired and informed much of Molecule’s positioning and goals.

In a compelling step forward, Sora Ventures has announced a significant investment in Molecule, marking a pivotal step towards integrating Decentralized Science (DeSci) in Asia.

We believe in a new era of scientific exploration powered by Decentralized Science (DeSci). This emerging concept, grounded in the principles of Meta- and Open-Science, leverages blockchain technology and decentralized networks to transform the lands

Moments that draw a community together act as an accelerant to progress. We recently hosted DeSci.Berlin 2023, facilitating essential conversations between key role players and encouraging knowledge to be dispensed liberally throughout the ecosystem.

Intellectual property is the expression of human creativity and innovation. It's the invisible fortress that protects our ideas, safeguarding them not as mere thoughts but as valuable assets. Intellectual property is the recognition that our...

Moving research from concept to market is like conducting a symphony - there are numerous players and stakeholders, each bringing their unique expertise to work in harmony and advance a project. As research continues to speed up and span across...

On a recent episode of The DeSci Podcast, Vincent Weisser interviewed Vitalk Buterin, co-founder of the Ethereum Foundation, to talk about the state of decentralized science today and its prospects for the future which led to an in-depth analysis of the potential curveballs and unknowns.

This episode of the Desci Podcast explores decentralized science with Balaji Srinivasan. Balaji discusses the Network State, an era of decentralized academia, decentralized media, and decentralized science, and the difference between "science" and actual science.